BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 14629602)

  • 1. Characteristics and effects of inflammation in end-stage renal disease.
    Kaysen GA; Eiserich JP
    Semin Dial; 2003; 16(6):438-46. PubMed ID: 14629602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation in ESRD: causes and potential consequences.
    Kaysen GA; Kumar V
    J Ren Nutr; 2003 Apr; 13(2):158-60. PubMed ID: 12671842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The microinflammatory state in uremia: causes and potential consequences.
    Kaysen GA
    J Am Soc Nephrol; 2001 Jul; 12(7):1549-1557. PubMed ID: 11423586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malnutrition and chronic inflammation as risk factors for cardiovascular disease in chronic renal failure.
    Stenvinkel P
    Blood Purif; 2001; 19(2):143-51. PubMed ID: 11150801
    [No Abstract]   [Full Text] [Related]  

  • 5. [Inflammatory markers, nutritional parameters and polyunsaturated fatty acids in hemodialysis patients].
    Perunicić-Peković GB; Pljesa SI; Rasić ZR; Stanković SD; Ilić MN
    Med Pregl; 2007; 60 Suppl 2():43-7. PubMed ID: 18928156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Predictive and diagnostic factors of malnutrition in hemodialysis patients].
    Memoli B; Guida B; Saravo MT; Nastasi A; Trio R; Liberti R; D'Arcangelo R; Romano G; Esposito A; Cianciaruso B
    G Ital Nefrol; 2002; 19(4):456-66. PubMed ID: 12369050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
    Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
    Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation: cause of vascular disease and malnutrition in dialysis patients.
    Kaysen GA
    Semin Nephrol; 2004 Sep; 24(5):431-6. PubMed ID: 15490405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of oxidative stress-altered lipoprotein structure and function and microinflammation on cardiovascular risk in patients with minor renal dysfunction.
    Kaysen GA; Eiserich JP
    J Am Soc Nephrol; 2004 Mar; 15(3):538-48. PubMed ID: 14978155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of albumin and C-reactive protein variations in 300 end stage renal disease patients in Tehran University of Medical Sciences Hospitals during year 2010.
    Dashti N; Einollahi N; Nabatchian F; Moradi Sarabi M; Zarebavani M
    Acta Med Iran; 2012; 50(3):197-202. PubMed ID: 22418989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are insulin-like growth factor and its binding proteins 1 and 3 clinically useful as markers of malnutrition, sarcopenia and inflammation in end-stage renal disease?
    Axelsson J; Qureshi AR; Divino-Filho JC; Bárány P; Heimbürger O; Lindholm B; Stenvinkel P
    Eur J Clin Nutr; 2006 Jun; 60(6):718-26. PubMed ID: 16391585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy.
    Suliman ME; Heimbürger O; Bárány P; Anderstam B; Pecoits-Filho R; Rodríguez Ayala E; Qureshi AR; Fehrman-Ekholm I; Lindholm B; Stenvinkel P
    J Am Soc Nephrol; 2003 Jun; 14(6):1614-22. PubMed ID: 12761263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal and cross-sectional effects of C-reactive protein, equilibrated normalized protein catabolic rate, and serum bicarbonate on creatinine and albumin levels in dialysis patients.
    Kaysen GA; Greene T; Daugirdas JT; Kimmel PL; Schulman GW; Toto RD; Levin NW; Yan G;
    Am J Kidney Dis; 2003 Dec; 42(6):1200-11. PubMed ID: 14655192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation and malnutrition as predictors of mortality in patients on hemodialysis.
    Fernández-Reyes MJ; Alvarez-Ude F; Sánchez R; Mon C; Iglesias P; Díez JJ; Vázquez A
    J Nephrol; 2002; 15(2):136-43. PubMed ID: 12018629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of inflammation and its treatment in ESRD patients.
    Kaysen GA
    Blood Purif; 2002; 20(1):70-80. PubMed ID: 11803162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory cytokines and malnutrition as related to risk for cardiovascular disease in hemodialysis patients.
    Perunicic-Pekovic G; Pljesa S; Rasic-Milutinovic Z; Stankovic S; Ilic M; Maletic R
    Can J Physiol Pharmacol; 2008 Apr; 86(4):205-9. PubMed ID: 18418430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative analysis of nutritional parameters as predictors of outcome in male and female ESRD patients.
    Stenvinkel P; Barany P; Chung SH; Lindholm B; Heimbürger O
    Nephrol Dial Transplant; 2002 Jul; 17(7):1266-74. PubMed ID: 12105251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of malnutrition-inflammation score, dialysis-malnutrition score and serum albumin with novel risk factors for cardiovascular diseases in hemodialysis patients.
    As'habi A; Tabibi H; Hedayati M; Mahdavi-Mazdeh M; Nozary-Heshmati B
    Ren Fail; 2015 Feb; 37(1):113-6. PubMed ID: 25296104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approaches to the reversal of malnutrition, inflammation, and atherosclerosis in end-stage renal disease.
    Caglar K; Hakim RM; Ikizler TA
    Nutr Rev; 2002 Nov; 60(11):378-87. PubMed ID: 12462522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation nutritional state and outcome in end stage renal disease.
    Kaysen GA
    Miner Electrolyte Metab; 1999; 25(4-6):242-50. PubMed ID: 10681647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.